Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

#RemoteDetailing

- PMLiVE

Evoke Kyne Named Communiqué Communications Consultancy of the Year 2021

Evoke KYNE took home the Communiqué Communications Consultancy of the Year award at the 2021 Communiqué Awards held on 1 September at the Grosvenor House hotel in London.David Kyne, CEO, Evoke KYNE said:...

Inizio

- PMLiVE

Michael Grela Elected President of the Society for Health Communication

February 8, 2022 – Michael Grela, Evoke KYNE’s EVP, Head of Reputation and Social Impact, has been elected President of the Society for Health Communication, a member-driven organization working to advance the science...

Inizio

- PMLiVE

Evoke Kyne Appoints Maureen Byrne to President and Promotes Four Executive Leaders

New York, April 27, 2022 – Evoke KYNE, an award-winning health communications agency, today announced the appointment of Maureen Byrne to President. Byrne will assume global leadership responsibilities from David Kyne including management of its...

Inizio

- PMLiVE

First evidence-based guide launched to put patients at heart of digital innovations

Produced by the University of Plymouth, the Academic Health Science Network and Boehringer Ingelheim, the guide follows the UK government’s plan to revolutionise digital health and social care

Early communications in Pharma: How effective pre-approval comms delivers launch success

What communications are required for a successful launch

Dice Medical Communications

Create Health Showreel

Create Health

- PMLiVE

AstraZeneca acquires TeneoTwo in a deal worth up to $1.27bn

The acquisition includes TeneoTwo’s phase 1 clinical-stage T-cell engager

- PMLiVE

Cancer Research UK urges government to realise ‘science superpower’ ambitions as new report highlights ‘huge’ economic value

Researchers revealed that in 2020/21, the £1.8bn invested in cancer research generated more than £5bn of economic impact

- PMLiVE

Novartis UK launches first health-tech investor partnership to address cardiovascular care

Partners include Medtronic, RYSE Asset Management and Chelsea and Westminster Hospital NHS Foundation Trust and its official charity CW+

- PMLiVE

UK government invests £175m to ‘supercharge’ clinical research

The £175m adds to the £200m in funding announced earlier this year to strengthen the national data infrastructure

- PMLiVE

New Omicron sub-variants cause COVID-19 cases to rise in the UK

The latest figures from the Office for National Statistics show infection rates in the UK have more than doubled since the start of June

- PMLiVE

Sanofi Global Health unveils new nonprofit Impact brand

The brand will enable 30 Sanofi medicines to be distributed to 40 low-income countries

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links